Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	120033
Country	China

Category	Oncology
Manuscript Type	Correspondence
Article Title	Letter to the Editor: Programmed death-1/programmed death-ligand 1 inhibitors in the treatment of elderly patients with advanced pancreatic cancer
Manuscript Source	Invited Manuscript
All Author List	Yan Feng, Hai-Wei Yu and Ke Xu
Funding Agency and Grant Number
Corresponding Author	Ke Xu, MD, Department of Oncology, The First Affiliated Hospital of Chengdu Medical College, No. 278 Baoguang Street, Xindu District, Chengdu 610500, Sichuan Province, China. xuke@cmc.edu.cn
Key Words	Elderly; Advanced pancreatic cancer; Programmed death-1 inhibitors; Prognosis; Safety
Core Tip	The recent study by Lu et al identified Eastern Cooperative Oncology Group performance status, prognostic nutritional index, and triglyceride levels as independent predictors for progression-free survival and overall survival in elderly patients with advanced pancreatic cancer receiving programmed death-1 inhibitors. While the results still need further verification, this work provides important clues in this underexplored research domain.
Citation	Feng Y, Yu HW, Xu K. Letter to the Editor: Programmed death-1/programmed death-ligand 1 inhibitors in the treatment of elderly patients with advanced pancreatic cancer. World J Gastrointest Oncol 2026; In press

Received	2026-02-13 02:03
Peer-Review Started	2026-02-13 02:04
First Decision by Editorial Office Director	2026-02-25 03:18
Return for Revision	2026-02-25 03:18
Revised	2026-03-02 03:35
Publication Fee Transferred
Second Decision by Editor	2026-04-13 02:42
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2026-04-13 09:24
Articles in Press	2026-04-13 09:24
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com